logo
Plus   Neg
Share
Email

Pfizer To Invest $500 Mln In Gene Therapy Manufacturing Plant

Pfizer Inc. (PFE) said that it will invest $500 million to construct its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina. The expanded facility is projected to add about 300 new jobs.

The company expects the facility will support its continuing investment in gene therapy research and development, similar to its Chapel Hill and Kit Creek, North Carolina research and development sites.

The facility would expand the company's presence in North Carolina, where there are currently more than 3,600 Pfizer staff, including 650 in Sanford.

In addition to its gene therapy operations, employees at Pfizer's Sanford facility also manufacture components for the company's vaccine portfolio, including Prevnar 13 and several vaccines currently in Pfizer's research pipeline.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) unveiled a 16-inch MacBook Pro laptop with a larger screen and redesigned keyboard. It is the first major update since the MacBook Pro line was revamped three years ago. The company has moved from a 15-inch screen to a higher-resolution 16-inch screen. Facebook has launched its new payment platform called 'Facebook Pay' in the U.S., joining other tech giants like Google and Apple that have their own payment platforms. The new service will be available across Facebook and its associated apps - Messenger, Instagram and WhatsApp, the social media giant said in a blog post. The payment service supports most major credit and debit cards. Amneal Pharmaceuticals, LLC recalled certain lots of heartburn medication Ranitidine in the form of tablets and syrup for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine, above levels established by the U.S. Food and Drug Administration or FDA. The generic and specialty pharma company is recalling 94 lots of Ranitidine tablets and Syrup.
Follow RTT
>